PERSPECTA

News from every angle

← Back to headlines

Cantor Fitzgerald Lowers Price Target for Apellis Pharmaceuticals (APLS)

Cantor Fitzgerald has reduced its price target for Apellis Pharmaceuticals (APLS) from $35 to $31.

31 Mar, 15:06 — 31 Mar, 15:06
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual143d ago

Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 – Here’s Why

Read full article →

Related Stories

TikTok Settles US Children's Privacy Case for $400 Million

31m ago

Tesla Leads Massive Vehicle Recall in China Over Safety Risks

1h ago

Youth Congress and ABVP Members Clash Ahead of Rahul Gandhi Event

1h ago

Apple Cuts Over 200 Jobs in Siri and Vision Pro Teams Amid AI Shift

2h ago